Skip to main content
. 2014 Oct 2;16(1):192–201. doi: 10.1208/s12249-014-0210-z

Fig. 3.

Fig. 3

The approximate occurrence of residual particles containing 0, 1, or more than 1 drug particle (left y-axis) and residual MMAD (right y-axis) with respect to drug concentration for micronized suspended drug with a MMAD of 2.5 μm (GSD of 2.0) for a HFA-134a formulation containing 8% (w/w) ethanol and no other excipients